PECAM1 and breast cancer: For example, one study found that tumour-associated endothelial cells (TECs) in breast cancer undergoing EndMT downregulated the endothelial-like marker PECAM1 and demonstrated enhanced migration and extracellular matrix remodeling capabilities compared to normal endothelial cells 35.